These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38733272)

  • 1. Research progress on the quality control of mRNA vaccines.
    Hu C; Bai Y; Liu J; Wang Y; He Q; Zhang X; Cheng F; Xu M; Mao Q; Liang Z
    Expert Rev Vaccines; 2024; 23(1):570-583. PubMed ID: 38733272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA.
    Zimmermann L; Erbar S
    Methods Mol Biol; 2024; 2786():135-144. PubMed ID: 38814392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA-based vaccines - global approach, challenges, and could be a promising wayout for future pandemics.
    Makhijani S; Elossaily GM; Rojekar S; Ingle RG
    Pharm Dev Technol; 2024 Jul; 29(6):559-565. PubMed ID: 38814266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential of mRNA Vaccines to Fight Against Viruses.
    Wang X
    Viral Immunol; 2024 Oct; 37(8):383-391. PubMed ID: 39418074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.
    Zhang C; Wang Y; Peng J; Wen X; Zhang Y; Li K; Du H; Hu X
    Hum Vaccin Immunother; 2024 Dec; 20(1):2355037. PubMed ID: 38813652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 mRNA vaccines.
    Huang Q; Zeng J; Yan J
    J Genet Genomics; 2021 Feb; 48(2):107-114. PubMed ID: 34006471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccine development based on RNA technology platforms].
    Guo X; Li J; Wang HM; Qiu J; Li Z; Huang F; Li J; Sun XD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Aug; 58(8):1263-1277. PubMed ID: 39142899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA vaccines: a new era in vaccine development.
    Chandra S; Wilson JC; Good D; Wei MQ
    Oncol Res; 2024; 32(10):1543-1564. PubMed ID: 39308511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size.
    Shi R; Liu X; Wang Y; Pan M; Wang S; Shi L; Ni B
    Hum Vaccin Immunother; 2024 Dec; 20(1):2342592. PubMed ID: 38714327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine.
    Files JK; Goepfert PA
    Top Antivir Med; 2024 Apr; 32(2):420-430. PubMed ID: 39141920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook.
    Verma A; Awasthi A
    Curr Pharm Des; 2024; 30(14):1049-1059. PubMed ID: 38551046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancement in the development of mRNA-based vaccines for respiratory viruses.
    Troncoso-Bravo T; Ramírez MA; Loaiza RA; Román-Cárdenas C; Papazisis G; Garrido D; González PA; Bueno SM; Kalergis AM
    Immunology; 2024 Nov; 173(3):481-496. PubMed ID: 39161170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 mRNA vaccines: Platforms and current developments.
    Szabó GT; Mahiny AJ; Vlatkovic I
    Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses.
    Shoja Doost J; Fazel F; Boodhoo N; Sharif S
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.
    Kurup D; Schnell MJ
    Curr Opin Virol; 2021 Aug; 49():52-57. PubMed ID: 34049261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to RNA Vaccines Post COVID-19.
    Kramps T
    Methods Mol Biol; 2024; 2786():1-22. PubMed ID: 38814388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines on demand, part II: future reality.
    Geall AJ; Kis Z; Ulmer JB
    Expert Opin Drug Discov; 2023 Feb; 18(2):119-127. PubMed ID: 36384351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled mRNA vaccines.
    Kim J; Eygeris Y; Gupta M; Sahay G
    Adv Drug Deliv Rev; 2021 Mar; 170():83-112. PubMed ID: 33400957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.